CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
receiving lower radiation doses, in patients with locally advanced pancreatic cancer, without increasing the rate of serious gastro...
Portland, Oregon, United States and 12 other locations
pegol-mknl in combination with cobimetinib in treating patients with pancreatic cancer that has spread to nearby tissue or lymph no...
Phase 1
Portland, Oregon, United States
phosphorylase (MTAP)-deleted gastrointestinal, biliary tract, or pancreatic cancers. The study also aims to determine the safety pr...
Phase 1
Vancouver, Washington, United States and 24 other locations
This early phase I trial aims to determine how cobimetinib, olaparib, onvansertib, azenosertib, AZD5305 or tremelimumab works in patients with pancreatic...
Early Phase 1
Portland, Oregon, United States
A Phase Ib/II, open-label, multicenter, randomized study designed to assess the safety, tolerability, pharmacokinetics and preliminary anti-tumor...
Phase 1, Phase 2
Portland, Oregon, United States and 26 other locations
The study is a multi-center, open-label, randomized active controlled study of subjects with locally advanced pancreatic adenocarcinoma whic...
Phase 3
Portland, Oregon, United States and 38 other locations
This trial will study tisotumab vedotin to find out whether it is an effective treatment alone or with other anticancer drugs for certain solid tumors...
Phase 2
Portland, Oregon, United States and 71 other locations
and efficacy of 9-ING-41, a potent GSK-3β inhibitor, as a single agent and in combination with cytotoxic agents, in patients with refractory cancers...
Phase 2
Portland, Oregon, United States and 65 other locations
in treating patients with sarcoma, prostate, breast, ovarian or pancreatic cancer that may have spread from where it first started ...
Phase 2
Portland, Oregon, United States
This is a Phase 1/2, first-in-human, open-label, dose escalation and dose-expansion study of E-602, administered alone and in combination with cemipl...
Phase 1, Phase 2
Portland, Oregon, United States and 12 other locations
Clinical trials
Research sites
Resources
Legal